Marcelo Martins Pinto-Filho

Marcelo Martins Pinto-Filho

Auto-generated profile, based on publicly available information

Marcelo Martins Pinto-Filho

Universidade Federal de Minas Gerais

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ELEmilly M. Lima
Emilly M. Lima
ARAntônio H. Ribeiro
Antônio H. Ribeiro
GPGabriela M. M. Paixão
Gabriela M. M. Paixão
MRManoel Horta Ribeiro
Manoel Horta Ribeiro
MPMarcelo M. Pinto-Filho
Marcelo M. Pinto-Filho
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro
The electrocardiogram (ECG) is the most commonly used exam for the evaluation of cardiovascular diseases. Here we propose that the age predicted by artificial intelligence (AI) from the raw ECG (ECG-age) can be a measure of cardiovascular health. A deep neural network is trained to predict a patient’s age from the 12-lead ECG in the CODE study cohort (n = 1,558,415 patients). On a 15% hold-out split, patients with ECG-age more than 8 years greater than the chronological age have a higher mortality rate (hazard ratio (HR) 1.79, p < 0.001), whereas those with ECG-age more than 8 years smaller, have a lower mortality rate (HR 0.78, p < 0.001). Similar results are obtained in the external cohorts ELSA-Brasil (n = 14,236) and SaMi-Trop (n = 1,631). Moreover, even for apparent normal ECGs, the predicted ECG-age gap from the chronological age remains a statistically significant risk predictor. These results show that the AI-enabled analysis of the ECG can add prognostic information.

19 January 2022 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
GOGlaucia Oliveira
Glaucia Oliveira
LBLuisa Campos Caldeira Brant
Luisa Campos Caldeira Brant
CPCarisi Anne Polanczyk
Carisi Anne Polanczyk
DMDeborah Malta
Deborah Malta
ABAndreia Biolo
Andreia Biolo
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro
Sobre estas estatísticas Esta é a edição de 2021 da Estatística Cardiovascular – Brasil , um esforço multi-institucional para fornecer periodicamente informação atualizada sobre a epidemiologia das DCV e AVC no Brasil. Este relatório incorpora estatísticas oficiais fornecidas pelo Ministério da Saúde brasileiro e outros órgãos governamentais, pelo projeto GBD liderado pelo IHME da Universidade de Washington, além de dados gerados por outras fontes e estudos científicos, como coortes e registros, sobre as DCV e seus fatores de risco. Este [...] Sobre estas estatísticas Esta é a edição de 2021 da Estatística Cardiovascular – Brasil , um esforço multi-institucional para fornecer periodicamente informação atualizada sobre a epidemiologia das DCV e AVC no Brasil. Este relatório incorpora estatísticas oficiais fornecidas pelo Ministério da Saúde brasileiro e outros órgãos governamentais, pelo projeto GBD liderado pelo IHME da Universidade de Washington, além de dados gerados por outras fontes e estudos científicos, como coortes e registros, sobre as DCV e seus fatores de risco. Este

1 February 2024 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
GOGlaucia Oliveira
Glaucia Oliveira
LBLuisa Campos Caldeira Brant
Luisa Campos Caldeira Brant
CPCarisi Anne Polanczyk
Carisi Anne Polanczyk
DMDeborah Malta
Deborah Malta
ABAndreia Biolo
Andreia Biolo
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro
SOBRE ESTE DOCUMENTO A publicação Estatística Cardiovascular – Brasil tem por objetivo fornecer uma compilação anual dos dados e das pesquisas sobre a epidemiologia das DCV no Brasil. Este documento congrega as estatísticas oficiais do Ministério da Saúde do Brasil e outras entidades governamentais ao lado de dados do projeto GBD, coordenado pelo IHME da Universidade de Washington. Além disso, incorpora dados derivados de várias fontes e estudos científicos, inclusive coortes e registros, relacionados às DCV e fatores de risco [...] SOBRE ESTE DOCUMENTO A publicação Estatística Cardiovascular – Brasil tem por objetivo fornecer uma compilação anual dos dados e das pesquisas sobre a epidemiologia das DCV no Brasil. Este documento congrega as estatísticas oficiais do Ministério da Saúde do Brasil e outras entidades governamentais ao lado de dados do projeto GBD, coordenado pelo IHME da Universidade de Washington. Além disso, incorpora dados derivados de várias fontes e estudos científicos, inclusive coortes e registros, relacionados às DCV e fatores de risco

3 February 2022 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
LBLuisa Campos Caldeira Brant
Luisa Campos Caldeira Brant
LPLuiz Guilherme Passaglia
Luiz Guilherme Passaglia
MPMarcelo Martins Pinto-Filho
Marcelo Martins Pinto-Filho
FCFabio Morato de Castilho
Fabio Morato de Castilho
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro
BNBruno Ramos Nascimento
Bruno Ramos Nascimento

23 April 2021 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Open access
PDF file
SGSebastian Garcia-Zamora
Sebastian Garcia-Zamora
SLSharen Lee
Sharen Lee
SHSohaib Haseeb
Sohaib Haseeb
George BazoukisGeorge Bazoukis
George Bazoukis
GTGary Tse
Gary Tse
ABAdrian Marco Baranchuk
Adrian Marco Baranchuk
Background: Coronavirus disease 2019 (COVID‐19) primarily causes lung infection, but recent studies have shown that cardiac involvement is associated with a worse prognosis.Objectives: We conducted a systematic review and meta‐analysis to examine the prevalence of cardiac arrhythmias detected by the electrocardiogram and their relationships with adverse outcomes in patients with COVID‐19.Methods: PubMed and Google were searched for studies that reported on cardiac arrhythmias and/or examined the relationship between arrhythmias and adverse outcomes.Results: Thirty studies with 12,713 participants were included in the systematic review, and 28 studies (n = 12,499) in the meta‐analysis. The mean age was 61.3 ± 16.8 years; 39.3% were female. In 25 studies with 7578 patients, the overall prevalence of cardiac arrhythmias was 10.3% (95% confidence interval [CI]: 8.4%–12.3%). The most common arrhythmias documented during hospitalization were supraventricular arrhythmias (6.2%, 95% CI: 4.4%–8.1%) followed by ventricular arrhythmias (2.5%, 95% CI: 1.8%–3.1%). The incidence of cardiac arrhythmias was higher among critically ill patients (relative risk [RR]: 12.1, 95% CI: 8.5–17.3) and among non‐survivors (RR: 3.8, 95%, CI: 1.7–8.7). Eight studies reported changes in the QT interval. The prevalence of QTc > 500 ms was 12.3% (95% CI: 6.9%–17.8%). ST‐segment deviation was reported in eight studies, with a pooled estimate of 8.7% (95% CI: 7.3% to 10.0%).Conclusion: Our meta‐analysis showed that QTc prolongation, ST‐segment deviation, and various other cardiac arrhythmias were observed in patients hospitalized with COVID‐19. The presence of cardiac arrhythmias was associated with a worse prognosis.

1 July 2023 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
LBLuisa C.C. Brant
Luisa C.C. Brant
ARAntonio Luiz Ribeiro
Antonio Luiz Ribeiro
MPMarcelo M. Pinto-Filho
Marcelo M. Pinto-Filho
JKJelena Kornej
Jelena Kornej
SPSarah R. Preis
Sarah R. Preis
HLHonghuang Lin
Honghuang Lin
BACKGROUND: Deep neural networks have been used to estimate age from ECGs, the electrocardiographic age (ECG-age), which predicts adverse outcomes. However, this prediction ability has been restricted to clinical settings or relatively short periods. We hypothesized that ECG-age is associated with death and cardiovascular outcomes in the long-standing community-based FHS (Framingham Heart Study). METHODS: We tested the association of ECG-age with chronological age in the FHS cohorts in ECGs from 1986 to 2021. We calculated the gap between chronological and ECG-age (Δage) and classified individuals as having normal, accelerated, or decelerated aging, if Δage was within, higher, or lower than the mean absolute error of the model, respectively. We assessed the associations of Δage, accelerated and decelerated aging with death or cardiovascular outcomes (atrial fibrillation, myocardial infarction, and heart failure) using Cox proportional hazards models adjusted for age, sex, and clinical factors. RESULTS: The study population included 9877 FHS participants (mean age, 55±13 years; 54.9% women) with 34 948 ECGs. ECG-age was correlated to chronological age (r=0.81; mean absolute error, 9±7 years). After 17±8 years of follow-up, every 10-year increase of Δage was associated with 18% increase in all-cause mortality (hazard ratio [HR], 1.18 [95% CI, 1.12–1.23]), 23% increase in atrial fibrillation risk (HR, 1.23 [95% CI, 1.17–1.29]), 14% increase in myocardial infarction risk (HR, 1.14 [95% CI, 1.05–1.23]), and 40% increase in heart failure risk (HR, 1.40 [95% CI, 1.30–1.52]), in multivariable models. In addition, accelerated aging was associated with a 28% increase in all-cause mortality (HR, 1.28 [95% CI, 1.14–1.45]), whereas decelerated aging was associated with a 16% decrease (HR, 0.84 [95% CI, 0.74–0.95]). CONCLUSIONS: ECG-age was highly correlated with chronological age in FHS. The difference between ECG-age and chronological age was associated with death, myocardial infarction, atrial fibrillation, and heart failure. Given the wide availability and low cost of ECG, ECG-age could be a scalable biomarker of cardiovascular risk.